<DOC>
	<DOCNO>NCT02423941</DOCNO>
	<brief_summary>To evaluate whether retrograde caval reperfusion liver graft could superior antegrade portal reperfusion regard incidence severity early allograft liver dysfunction . All eligible enrol liver transplant candidate randomize receive either : 1. retrograde caval , follow sequential portal-arterial , reperfusion 2. antegrade , sequential portal-arterial reperfusion .</brief_summary>
	<brief_title>A Study Retrograde rEperfusion Dbd Donor LIver Transplantation</brief_title>
	<detailed_description>We hypothesize retrograde caval reperfusion could superior antegrade portal reperfusion regard incidence severity early allograft liver dysfunction . Chi-square method sample size estimation a=0,05 , b=0,20 P1-P2 = 0,25 require 41 subject per group ( Stephen B Hulley , Steven R Cummings , Warren S Browner , Deborah G Grady , Thomas B Newman.-4th ed . Lippincott Williams &amp; Wilkins , 2013 ) . After sign informed consent 90 patient randomize study active-control group ( 45 ) . Only patient undergoing classical technique ( retrohepatic IVC resection ) liver transplantation without vena-venous bypass enrol study . In study group completion caval anastomosis ( super infra-hepatic ) infra-hepatic cava-clamp release remove allow fill flush liver retrogradely hepatic vein . 300 ml blood drain via donor portal vein vein clamp . Suprahepatic cava-clamp release remove allow venous return right atrium . Portal vein anastomosis construct . Before last 2-3 stitch another 100 ml drain retrogradely . Recipient portal vein clamp remove liver reperfused antegradely . After arterial biliary anastomosis construct . In control group cava-clamps remove completion portal vein anastomosis . Chi-square test regression analysis use test difference incidence early allograft liver dysfunction study group . Mann-Whitney test use compare median high aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) level 24 48 hour post-reperfusion .</detailed_description>
	<mesh_term>Delayed Graft Function</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Donor decease brain dead age 1859 length ICU treatment 7 day high AST ALT 200 UI/L macroscopic steatosis 30 % high serum sodium 165 mmol/L high bilirubin 25 µmol/L application norepinephrine allow preservation solution HTK ( Custodiol ) Recipient inclusion Criteria : age 1869 primary liver transplant fullsize transplant Technique liver transplant : IVC resection ; without venovenous bypass ; sequential portalarterial reperfusion flush portal vascular bed 500 ml call 24 °C saline backtable implantataion Recipient exclusion Criteria : live donor liver transplant reduce split graft ; multi organ failure ( include fulminant UNOS status 1 ) ; fulminant hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Liver Transplantation</keyword>
	<keyword>Retrograde Reperfusion</keyword>
	<keyword>Graft dysfunction</keyword>
	<keyword>Randomized study</keyword>
</DOC>